These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 34449705

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of selective serotonin reuptake inhibitors on endocrine system (Review).
    Ruiz-Santiago C, Rodríguez-Pinacho CV, Pérez-Sánchez G, Acosta-Cruz E.
    Biomed Rep; 2024 Sep; 21(3):128. PubMed ID: 39070109
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Second generation SSRIS: human monoamine transporter binding profile of escitalopram and R-fluoxetine].
    Owens JM, Knight DL, Nemeroff CB.
    Encephale; 2002 Sep; 28(4):350-5. PubMed ID: 12232544
    [Abstract] [Full Text] [Related]

  • 7.
    Sobieraj DM, Baker WL, Martinez BK, Hernandez AV, Coleman CI, Ross JS, Berg KM, Steffens DC.
    ; 2019 03. PubMed ID: 30964616
    [Abstract] [Full Text] [Related]

  • 8. SSRI differentiation: Pharmacology and pharmacokinetics.
    Leonard BE.
    Hum Psychopharmacol; 1995 Oct; 10 Suppl 3(S3):S149-S158. PubMed ID: 29569414
    [Abstract] [Full Text] [Related]

  • 9. Selectivity of SSRIs: individualising patient care through rational treatment choices.
    Stahl SM.
    Int J Psychiatry Clin Pract; 2004 Oct; 8 Suppl 1():3-10. PubMed ID: 24930682
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data.
    Solem CT, Shelbaya A, Wan Y, Deshpande CG, Alvir J, Pappadopulos E.
    Neuropsychiatr Dis Treat; 2016 Oct; 12():2755-2764. PubMed ID: 27822048
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Estrogenic/antiestrogenic activity of selected selective serotonin reuptake inhibitors.
    Pop A, Lupu DI, Cherfan J, Kiss B, Loghin F.
    Clujul Med; 2015 Oct; 88(3):381-5. PubMed ID: 26609273
    [Abstract] [Full Text] [Related]

  • 16. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC.
    Handb Exp Pharmacol; 2019 Oct; 250():145-180. PubMed ID: 30838456
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of selective serotonin reuptake inhibitors on rating-scale-assessed suicidality in adults with depression.
    Näslund J, Hieronymus F, Lisinski A, Nilsson S, Eriksson E.
    Br J Psychiatry; 2018 Mar; 212(3):148-154. PubMed ID: 29436321
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.